Edition:
United Kingdom

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

43.92USD
15 Jan 2019
Change (% chg)

$-2.52 (-5.43%)
Prev Close
$46.44
Open
$43.94
Day's High
$45.15
Day's Low
$41.85
Volume
322,219
Avg. Vol
152,074
52-wk High
$59.54
52-wk Low
$32.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 3.26 -0.629
Jun '18 3.68 -0.632
Mar '18 3.23 -0.576
FY 2017 Dec '17 3.70 -0.617
Sep '17 3.01 -0.647
Jun '17 3.06 -0.768
Mar '17 3.70 -0.662
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 15.86 30.36 4.00 --
Quarter Ending Jun-19 4 18.79 42.50 0.00 --
Year Ending Dec-19 12 52.66 97.10 17.50 78.34
Earnings (per share)
Quarter Ending Mar-19 5 -0.50 -0.08 -0.76 --
Quarter Ending Jun-19 5 -0.38 0.03 -0.81 --
Year Ending Dec-19 13 -2.13 -1.35 -2.87 -1.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.38
P/E High - Last 5 Yrs. -- 148.01 46.19
P/E Low - Last 5 Yrs. -- 47.79 24.58
Beta 1.66 1.08 0.91
Price to Sales (TTM) 127.91 49.51 6.26
Price to Book (MRQ) 7.82 10.16 5.20
Price to Tangible Book (MRQ) 8.91 13.82 6.73
Price to Cash Flow (TTM) -- 52.80 24.17
% Owned Institutions 82.71 3.75 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.93
Payout Ratio(TTM) -- 7.04 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -4.32 129.91 8.17
Sales (TTM) vs TTM 1 Yr. Ago -55.25 47.85 6.48
Sales - 5 Yr. Growth Rate -19.25 22.76 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago -30.02 75.87 23.23
EPS (TTM) vs TTM 1 Yr. Ago -55.59 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate 162.73 9.25 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.30
Current Ratio (MRQ) 10.38 3.43 3.12
LT Debt to Equity (MRQ) 0.00 18.73 11.47
Total Debt to Equity (MRQ) 0.00 31.43 16.03
Interest Coverage (TTM) -- -43.27 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 54.45
Gross Margin - 5 Yr. Avg. -- 60.55 52.36
EBITD Margin (TTM) -731.42 -- --
EBITD - 5 Yr. Avg -145.29 -110.00 13.10
Operating Margin (TTM) -748.05 -184.40 6.05
Operating Margin - 5 Yr. Avg. -153.69 -126.43 8.39
Pre-Tax Margin (TTM) -723.96 -175.18 7.01
Pre-Tax Margin - 5 Yr. Avg. -170.41 -132.58 8.67
Net Profit Margin (TTM) -724.23 -181.91 3.11
Net Profit Margin - 5 Yr. Avg. -170.43 -136.98 4.86
Effective Tax Rate (TTM) -- 21.48 23.27
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 108,562 7,650,987 873,304,761
Net Income/Employee (TTM) -786,240 652,634 103,509,273
Receivable Turnover (TTM) 4.29 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.57
Asset Turnover (TTM) 0.05 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.42 6.45 11.45
Return on Assets - 5 Yr. Avg. -34.02 5.52 12.50
Return on Investment (TTM) -41.85 8.99 14.96
Return on Investment - 5 Yr. Avg. -40.72 6.86 16.23
Return on Equity (TTM) -44.00 10.14 16.53
Return on Equity - 5 Yr. Avg. -939.02 8.39 17.36
  1 Year 3 Year 5 Year
Sales % 53.46 -21.42 -19.25
EPS (TTM) % 20.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Acceleron Pharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.55 -2.91 43 98
13 Week 16.77 11.09 71 94
26 Week 44.23 33.27 80 98
52 Week 12.37 -4.76 59 68
YTD 49.49 31.28 73 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 97.98%
# of Holders: 244
Total Shares Held: 45,256,102
3 Mo. Net Change: 1,917
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 10
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.